These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

237 related articles for article (PubMed ID: 32884613)

  • 81. A Review of Systemic Minocycline Side Effects and Topical Minocycline as a Safer Alternative for Treating Acne and Rosacea.
    Martins AM; Marto JM; Johnson JL; Graber EM
    Antibiotics (Basel); 2021 Jun; 10(7):. PubMed ID: 34206485
    [TBL] [Abstract][Full Text] [Related]  

  • 82. The development of antimicrobial resistance due to the antibiotic treatment of acne vulgaris: a review.
    Patel M; Bowe WP; Heughebaert C; Shalita AR
    J Drugs Dermatol; 2010 Jun; 9(6):655-64. PubMed ID: 20645527
    [TBL] [Abstract][Full Text] [Related]  

  • 83. Designed Antimicrobial Peptides for Topical Treatment of Antibiotic Resistant Acne Vulgaris.
    Woodburn KW; Jaynes J; Clemens LE
    Antibiotics (Basel); 2020 Jan; 9(1):. PubMed ID: 31940992
    [TBL] [Abstract][Full Text] [Related]  

  • 84. [Biotyping of Propionibacterium acnes strains isolated from patients with acne vulgaris].
    Ergin C; Kaleli I; Sahin R; Ergin S; Kaçar N
    Mikrobiyol Bul; 2006; 40(1-2):15-21. PubMed ID: 16775952
    [TBL] [Abstract][Full Text] [Related]  

  • 85. Activation of Deoxyribonuclease I by Nicotinamide as a New Strategy to Attenuate Tetracycline-Resistant Biofilms of
    Shih YH; Liu D; Chen YC; Liao MH; Lee WR; Shen SC
    Pharmaceutics; 2021 May; 13(6):. PubMed ID: 34072745
    [TBL] [Abstract][Full Text] [Related]  

  • 86. Extraction of essential oil from
    Hou HS; Bonku EM; Zhai R; Zeng R; Hou YL; Yang ZH; Quan C
    Heliyon; 2019 Dec; 5(12):e02947. PubMed ID: 31872120
    [TBL] [Abstract][Full Text] [Related]  

  • 87. Long-term administration of oral macrolides for acne treatment increases macrolide-resistant Propionibacterium acnes.
    Nakase K; Okamoto Y; Aoki S; Noguchi N
    J Dermatol; 2018 Mar; 45(3):340-343. PubMed ID: 29235673
    [TBL] [Abstract][Full Text] [Related]  

  • 88. Antibiotic susceptibility in prostate-derived Propionibacterium acnes isolates.
    Olsson J; Davidsson S; Unemo M; Mölling P; Andersson SO; Andrén O; Söderquist B; Sellin M; Elgh F
    APMIS; 2012 Oct; 120(10):778-85. PubMed ID: 22958285
    [TBL] [Abstract][Full Text] [Related]  

  • 89.
    Ridberg S; Hellmark B; Nilsdotter Å; Söderquist B
    J Bone Jt Infect; 2019; 4(3):106-110. PubMed ID: 31192108
    [No Abstract]   [Full Text] [Related]  

  • 90. Development of a topical bacteriophage gel targeting
    Golembo M; Puttagunta S; Rappo U; Weinstock E; Engelstein R; Gahali-Sass I; Moses A; Kario E; Ben-Dor Cohen E; Nicenboim J; Ben David H; Sudakov K; Cohen A; Bassan M; Zak NB
    Skin Health Dis; 2022 Jun; 2(2):e93. PubMed ID: 35677920
    [TBL] [Abstract][Full Text] [Related]  

  • 91. Prevalence of antibiotic-resistant propionibacteria on the skin of acne patients: 10-year surveillance data and snapshot distribution study.
    Coates P; Vyakrnam S; Eady EA; Jones CE; Cove JH; Cunliffe WJ
    Br J Dermatol; 2002 May; 146(5):840-8. PubMed ID: 12000382
    [TBL] [Abstract][Full Text] [Related]  

  • 92. Propionibacterium/Cutibacterium species-related positive samples, identification, clinical and resistance features: a 10-year survey in a French hospital.
    Broly M; Ruffier d'Epenoux L; Guillouzouic A; Le Gargasson G; Juvin ME; Leroy AG; Bémer P; Corvec S
    Eur J Clin Microbiol Infect Dis; 2020 Jul; 39(7):1357-1364. PubMed ID: 32125556
    [TBL] [Abstract][Full Text] [Related]  

  • 93. Antibiotic-resistant acne: getting under the skin.
    Sinha M; Sadhasivam S; Bhattacharyya A; Jain S; Ghosh S; Arndt KA; Dover JS; Sengupta S
    Semin Cutan Med Surg; 2016 Jun; 35(2):62-7. PubMed ID: 27416310
    [TBL] [Abstract][Full Text] [Related]  

  • 94. Calcium sulphate mixed with antibiotics does not decrease efficacy against
    Couture A; Lavergne V; Sandman E; Leduc JM; Benoit B; Leduc S; Rouleau DM
    J Orthop; 2020; 19():138-142. PubMed ID: 32025121
    [TBL] [Abstract][Full Text] [Related]  

  • 95. The Microbiome and Acne: Perspectives for Treatment.
    Dessinioti C; Katsambas A
    Dermatol Ther (Heidelb); 2024 Jan; 14(1):31-44. PubMed ID: 38183614
    [TBL] [Abstract][Full Text] [Related]  

  • 96. Topical antibiotic monotherapy prescribing practices in acne vulgaris.
    Hoover WD; Davis SA; Fleischer AB; Feldman SR
    J Dermatolog Treat; 2014 Apr; 25(2):97-9. PubMed ID: 24171409
    [TBL] [Abstract][Full Text] [Related]  

  • 97. Potential functionality of Cutibacterium acnes extracellular vesicles in atopic dermatitis and acne vulgaris: A comparative proteomic analysis.
    Yu T; Chen J; Wu S; Jiang M; Han L; Ma Y
    Proteomics Clin Appl; 2024 Apr; ():e2300106. PubMed ID: 38639920
    [TBL] [Abstract][Full Text] [Related]  

  • 98.
    Li X; Ding W; Li Z; Yan Y; Tong Y; Xu J; Li M
    Microorganisms; 2024 Jul; 12(8):. PubMed ID: 39203407
    [TBL] [Abstract][Full Text] [Related]  

  • 99. Cutibacterium acnes Type II strains are associated with acne in Chinese patients.
    Zhao S; Ci J; Xue J; Wang Y; Li X; Hao L; Tian L; Guo H; Xin C; Zhao Y
    Antonie Van Leeuwenhoek; 2020 Mar; 113(3):377-388. PubMed ID: 31630297
    [TBL] [Abstract][Full Text] [Related]  

  • 100. Current issues in antimicrobial therapy for the treatment of acne.
    Leyden JJ
    J Eur Acad Dermatol Venereol; 2001; 15 Suppl 3():51-5. PubMed ID: 11843235
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.